Our funding programs support early stage, Ohio-based companies to achieve success.


Athersys is a Cleveland, Ohio based company developing a growing pipeline of therapeutics designed to treat cardiovascular disease and other conditions. Athersys is currently developing pharmaceutical-like cell therapies, based upon its proprietary multipotent adult progenitor cell technology, for the treatment of congestive heart failure, acute myocardial infarction and other cardiovascular conditions.

view all portfolio clients